Combination chemoimmunotherapy with the Bruton's tyrosine kinase (BTK) inhibitor ibrutinib demonstrated improved progression-free survival over standard chemoimmunotherapy for previously untreated mantle cell lymphoma (MCL) ...
Jun 3, 2022
0
35
Research from the Yale School of Medicine indicates that a protein kinase that is a master regulator of cell metabolism is critical to preventing atrial fibrillation. The research appeared April 22 in the journal JCI Insight.
Apr 26, 2022
0
42
Scientists have known for years that amyloid fibrils—fibrous, ropelike structures formed by closely linked protein molecules—are present in the brains of patients with Alzheimer's and Parkinson's diseases and likely play ...
Apr 20, 2022
0
124
A person's risk of developing diseases such as type 2 diabetes or breast cancer may be influenced by thousands of genetic differences. Looking at a single DNA difference that has a small effect on risk may not be clinically ...
Apr 18, 2022
0
85
For more than 30 years, scientists have been trying to unravel the mystery of how a key biological molecule self assembles into a rogue protein-like substance known as amyloid, which is thought to play a role in the development ...
Feb 24, 2022
0
98
New Year's Day, Super Bowl Sunday and other days when more people consume more alcohol are also associated with more emergency room visits for atrial fibrillation, an often-deadly heart rhythm disorder, reported a new study ...
Jan 12, 2022
0
79
For decades, patients with atrial fibrillation with a moderate or severe risk for stroke were prescribed the anticoagulant warfarin. With the emergence of a safer, more effective class of oral anticoagulants, new Yale-led ...
Dec 10, 2021
0
66
How ventricular fibrillation will behave in an individual patient can be accurately modeled and predicted using a single mathematical equation, according to Flinders University researchers.
Nov 8, 2021
0
51
Progress on treating Alzheimer's disease has been frustratingly slow. A group of scientists in Houston suggest frustration at a very small scale may lead to a new path toward treatment.
Sep 13, 2021
1
58
Johns Hopkins Medicine researchers say they have pinpointed the section of alpha-synuclein, a protein in the brain that causes it to latch onto brain cells called neurons and likely drives the development of Parkinson's disease, ...
Jul 29, 2021
0
593
